ARKO heads into its August 6 earnings print with a striking divergence between a relaxed lending market and an unusually sharp move in options positioning.
The options signal is the standout this week. Put/call ratio jumped to 8.12 on Tuesday — nearly four standard deviations above its 20-day average of 0.74. That reading puts the options market firmly in defensive territory, with put demand running at more than eight times call volume in a single session. The prior 20-day history shows the PCR was essentially flat around 0.15 for weeks, making Tuesday's spike look less like a structural re-rating and more like a concentrated hedge placed ahead of the August 6 print. One comparable cluster appeared on June 30, when the PCR briefly touched 4.13 before reverting the next day — suggesting these spikes tend to be episodic rather than sustained.
The lending market tells a very different story. Availability runs at roughly 1,256% — meaning shares available to borrow dwarf the shares already shorted by more than twelve to one. That is exceptionally loose. Short interest itself sits at 5.04% of free float, which is non-trivial, but the one-week change is essentially flat at minus 0.07%. The more notable move is the one-month build: shorts have grown roughly 38% since mid-June, adding close to a million shares net. Yet borrowing costs remain very cheap at 0.58%, up about 35% on the week but still firmly in low-cost territory. The combination — a month-long accumulation of shorts alongside abundant borrow and a low cost to borrow — suggests the positioning is deliberate and patient rather than squeezed or urgent.
The Street picture is less live than one would want. Analyst coverage data is stale as of May 2025, and the most recent formal target changes came from BMO Capital and Raymond James over a year ago. Raymond James held a Strong Buy with a $10 target at that point; BMO sat at Market Perform with $5. With the stock at $7.93 today, the Raymond James target still represents meaningful implied upside, but the data is dated enough to treat with caution. On valuation, the EV/EBITDA multiple has drifted down about 0.19 turns over the past month to 11.5x, while the PE has moved higher to around 90x — reflecting very thin trailing earnings rather than a re-rating on fundamentals. The ORTEX short score has climbed steadily from 50.1 to 55.0 over the past two weeks, a mild but consistent drift toward more bearish composite signal.
Insider flow adds some nuance. The General Counsel sold 35,000 shares across three tranches in early June, with proceeds around $280,000. Against that, the CFO bought just over $168,000 worth of stock in late March when the price was near $5. Net 90-day activity shows roughly 75,000 shares purchased, but that net is almost entirely driven by the March CFO buys at a significantly lower price. The two signals point in opposite directions, and the insider selling came as the stock climbed through the $7.50–$8.50 range. Institutional ownership remains concentrated: Davidson Kempner holds over 20% and has not adjusted its position, while BlackRock added about 626,000 shares through the end of June — one of the larger incremental moves in the register.
With Q2 results due on August 6, the most recent comparable prints offer useful context without predicting the outcome. The May 7 report produced a 5.4% gain on the day and a further 9.4% over the following week. The June 4 event (an investor or secondary print) moved just 0.1% on day one before rallying 15.2% over five sessions — though the nature of that event may differ from a standard earnings release. What to watch into the August print is whether the put-heavy options positioning this week represents a one-session anomaly or the beginning of a broader defensive shift, and whether the month-long buildup in short interest accelerates or fades as the release date approaches.
See the live data behind this article on ORTEX.
Open ARKO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
